Physician profile
Arpit A Shah
NPI 1083844518
$1,053.39
in general payments reported to CMS, 2019-2025
12 companies · $91.95 in 2025
The $91.95 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2021: $109 · 2022: $142 · 2023: $245 · 2024: $303 · 2025: $91.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $287.70 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $146.81 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.39 | 2023-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.35 | 2019-2024 | Jardiance, Spiriva Respimat |
| Pfizer INC. | $112.94 | 2019-2024 | |
| Gilead Sciences, INC. | $51.12 | 2023-2025 | Veklury |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.43 | 2022-2025 | Lifevest |
| Mylan Specialty L.P. | $45.54 | 2023-2024 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $37.74 | 2021-2022 | |
| Abbott Laboratories | $25.65 | 2025 | Mitraclip |
| Portola Pharmaceuticals, LLC | $19.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.